Thymopoietin
Thymic hormone that supports T-cell development and immune function, with the active fragment thymopentin (TP-5) used in clinical research
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Suggested dose
50 mg
Compound profile
Scientific & efficacy data
Immune
Peptide profile
Limited human trials
Thymopoietin
50 mg (as the active thymopentin/TP-5 pentapeptide) · Every other day
Molecular formula
C246H404N66O73
- Mol. weight
- 5454
- CAS number
- 67632-30-6
- PubChem
- 16132313
- Developed · 1975
- Gideon Goldstein
Memorial Sloan-Kettering Cancer Center / Immunobiology Research Institute
Amino acid sequence
49-amino acid polypeptide with active pentapeptide fragment (thymopentin/TP-5: Arg-Lys-Asp-Val-Tyr)Immune Cell Development
Thymopoietin directly induces differentiation of T-cell precursors into mature helper and cytotoxic T-cells, with robust evidence from multiple clinical studies.
Post-Surgical Recovery
Restores T-cell function and prevents immune suppression after major surgery, with randomized trials showing restoration of normal immune parameters.
Cancer Immunotherapy Enhancement
Combines effectively with chemotherapy to improve anti-tumor immunity while reducing hematologic toxicity, with established use in cancer treatment protocols.
Dosing
How much do I take?
50 mg · three times weekly
50 mg
Three times weekly
Covers timing · dose-adjustment guidance.
Suitability
Is this right for me?
Best for supporting immune function during cancer treatment & recovering immune function after surgery
Best for
Cancer Treatment Support
Used alongside chemotherapy to maintain immune function and reduce treatment side effects while enhancing anti-tumor immunity
Post-Surgical Immune Recovery
Helps restore T-cell function and prevent immune depression following major surgery or serious medical stress
HIV-Related Immune Support
Combined with antiretroviral therapy to support T-cell populations and improve immune response
Consider alternatives if
Do not use if
Use with caution if
Not sure?
Compare Thymopoietin with similar peptides to find the best fit for your goals.
Administration
How do I use it?
Subcutaneous injection · Intravenous injection
Route
Subcutaneous injection (primary method); can be intravenous under medical supervision
Best sites
Covers reconstitution · step-by-step technique · storage · a sample daily schedule.
Safety
Is it safe?
3 common side effects · 4 serious
Thymopoietin is a naturally-derived thymic hormone with a well-characterized mechanism but limited human safety data.
Most clinical experience comes from thymopentin (TP-5), the active pentapeptide fragment. It is generally well-tolerated but has important safety considerations, particularly regarding neuromuscular effects.
Safety profile based on limited clinical trials primarily using thymopentin, a simplified fragment. Full thymopoietin research is more limited. Always use under appropriate medical guidance.
Common side effects · experienced by some users
Injection site redness or swelling
Mild to moderate redness, warmth, or swelling at injection site lasting a few hours to a day
Management: Apply ice pack for 10 minutes, avoid rubbing area, rotate injection sites, use topical antihistamine if itching
Mild fever
Low-grade fever (99-101°F) within 24 hours of injection, may indicate immune activation
Management: Rest, stay hydrated, monitor temperature, take acetaminophen if uncomfortable
Transient lymphocytosis
Temporary increase in white blood cells, normal immune response to treatment
Management: Monitor with blood tests, usually resolves within days, indicates therapeutic effect
Less common
These typically resolve with continued use or dose adjustment.
Stop and seek help if
- Severe neuromuscular weakness or myasthenia-like symptoms appear
- Severe allergic reactions occur
- Signs of autoimmune disease flare up
- Persistent fever over 101.5°F
- Severe injection site reactions with spreading redness or warmth
- Pregnancy is discovered
- Diagnosed with myasthenia gravis or neuromuscular disorder
This information is educational. Always consult with a healthcare provider before starting, stopping, or changing thymopoietin use. Emergency symptoms require immediate medical attention.
With other peptides
- Caution:
- Caution:
- Caution:
With medications
- Caution:
- Caution:
- Caution:
- Caution:
- Caution:
- Caution:
With supplements
- Safe:
- Safe:
- Safe:
- Safe:
- Safe:
Effectiveness
How do I know it's working?
Limited human trials · first signs week 1
Evidence level
Limited human trials
Regulatory status
Research compound
Onset of effects
Moderate
(1-2 weeks)
How it works
Thymopoietin is a hormone made by your thymus gland (a small gland in your chest that trains immune cells).
Think of it like a coach that teaches young immune cells called T-cells how to do their job properly. When you inject thymopoietin, you're giving your immune system extra coaching to make more T-cells and help them work better. This can help your body fight infections and cancer.
The most commonly used part is thymopentin, which is just the five most important amino acids (building blocks) from the whole thymopoietin molecule.
The deeper mechanism
Thymopoietin is a 49-amino acid polypeptide hormone secreted by thymic epithelial cells that plays a central role in T-cell lymphopoiesis and differentiation.
The peptide works primarily through its bioactive pentapeptide fragment, thymopentin (TP-5: Arg-Lys-Asp-Val-Tyr, residues 32-36), which exerts immunomodulatory effects through multiple mechanisms: (1) Promotes differentiation of T-cell precursors into mature helper and cytotoxic T-cells by inducing expression of differentiation markers including CD4, CD8, and TCR expression; (2) Enhances IL-2 production and T-cell proliferation through restoration of IL-2 receptor expression; (3) Reduces T-cell apoptosis through anti-apoptotic signaling; (4) Modulates Th1/Th2 balance toward Th1 responses important for cellular immunity.
Clinically, thymopoietin and thymopentin support immune recovery in immunocompromised states including post-surgical immunosuppression, HIV-related CD4 depletion, and chemotherapy-induced lymphopenia.
The peptide also exhibits neuromuscular effects through interaction with acetylcholine receptors, which can be both therapeutic and potentially problematic in neuromuscular disorders.
What to expect
Week 1
What you might notice
- Mild injection site reactions (redness, warmth)
- Possible low-grade fever within first 24 hours
- Mild fatigue or flu-like feeling
- No dramatic changes yet
What's normal
- Local injection reactions are expected
- Mild fever indicates immune activation
- Body is still adjusting to peptide
What's next
- Continue dosing schedule
- Rotate injection sites to minimize local reactions
- Monitor temperature and general feelings
Week 2-3
What you might notice
- Reduced injection site reactions
- Improved energy or reduced fatigue
- Better recovery after physical activity
- Blood work may show increased lymphocytes
What's normal
- Stabilization of immune response
- Body adapting to treatment
- Transient lymphocytosis is expected and positive
What's next
- Continue standard dosing if tolerating well
- Schedule blood tests to assess T-cell counts
- Monitor for any neuromuscular symptoms
Week 4-6
What you might notice
- Improved immune function markers
- Reduced infection frequency
- Better response to other treatments (if used with chemotherapy)
- Sustained improvement in T-cell populations
What's normal
- Cumulative immune improvement
- More stable baseline energy levels
- Results align with expected therapeutic timeline
What's next
- Assess response to therapy with healthcare provider
- Determine if continuing, cycling, or stopping treatment
- Plan follow-up blood work
Signs it's working
Blood Work Markers
- Increased total lymphocyte count
- Improved CD4+ T-cell count (if HIV-positive)
- Improved helper T-cell ratio
- Better lymphocyte proliferation in lab tests
Clinical Outcomes
- Reduced frequency or severity of infections
- Faster recovery from illness
- Improved tolerance to chemotherapy
- Better overall energy and immune function
- Reduced cancer progression during treatment
Post-Surgical Recovery
- Faster wound healing
- Reduced post-surgical infections
- Restored normal T-cell distribution
- Return to normal immune-dependent functions
Not seeing results? Common reasons
- Not enough time has passed - immune changes take 2-4 weeks to manifest
- Injection site rotation inadequate - causing excessive local inflammation
- Dosing schedule inconsistency - missing doses or irregular timing reduces effect
- Concurrent immunosuppressive therapy - high-dose corticosteroids or immunosuppressants block thymopoietin effect
- Underlying condition preventing response - advanced cancer, severe malnutrition, or uncontrolled infections reduce effectiveness
Key research
Questions
Frequently asked
What's the difference between thymopoietin and thymopentin?
Thymopoietin is the full 49-amino acid hormone from your thymus gland. Thymopentin (TP-5) is a smaller, 5-amino acid active fragment (residues 32-36) that contains the key therapeutic effects. Most clinical research and use has been with thymopentin because it's simpler, easier to make, and still provides the immune benefits. Both work similarly to boost T-cell production.
How quickly will I see immune improvement?
Most people don't notice dramatic changes right away. Immune system changes typically take 2-4 weeks to become measurable. You might see improved energy or faster recovery from illness within the first month. Blood tests showing improved T-cell counts are usually the first measurable changes, often visible within 2-3 weeks.
Can I use thymopoietin if I have an autoimmune disease?
No, thymopoietin should NOT be used if you have active autoimmune disease like lupus, rheumatoid arthritis, or Hashimoto's thyroiditis, because it strengthens the immune system which could make autoimmune symptoms worse. However, it may have been studied in rheumatoid arthritis at very specific doses and routes - always check with your doctor first.
What should I do if I develop muscle weakness after starting thymopoietin?
Stop using it immediately and contact your doctor. Muscle weakness, difficulty swallowing, or drooping eyelids could indicate neuromuscular blocking effects. This is a serious side effect. Do not ignore it - get medical help right away. This is why thymopoietin should never be used by people with myasthenia gravis.
Can I combine thymopoietin with chemotherapy?
Yes, in fact, combining thymopoietin or thymopentin with chemotherapy may improve outcomes. Research shows it can make chemotherapy more effective while reducing some side effects on blood cell production. However, this should only be done under medical supervision, and your oncologist should be aware you are using it.
How often should I rotate my injection sites?
Rotate your injection sites with every dose. You have three main areas: upper arm (abdomen side), abdomen, and outer thigh. Use a different site for each injection to prevent excessive local reactions. Even within the abdomen, vary the spot (upper left, upper right, lower left, lower right).
Is thymopoietin FDA-approved?
No, thymopoietin is not FDA-approved as a drug in the United States. Most clinical research has used thymopentin, the active fragment. Thymopoietin and thymopentin are available in some countries outside the U.S. and in research settings, but they are not available as prescription medications in the U.S.
Can I take thymopoietin if I'm pregnant or breastfeeding?
No, thymopoietin should not be used during pregnancy or while breastfeeding. There is not enough safety data in pregnant women, and it could potentially affect fetal immune development. If you are trying to conceive, discuss with your doctor when it would be safe to stop.
Further reading
History & related research
History · since 1966
A 49-amino-acid immune hormone that bridges thymic and neuromuscular systems.
A 49-amino-acid immune hormone that bridges thymic and neuromuscular systems. Its active pentapeptide fragment (TP-5) regulates T-cell differentiation while also binding acetylcholine receptors.
Read the full history of ThymopoietinReady for the protocol?
Every dosing tier, administration route, timing note, and dose-adjustment rule for Thymopoietin, on one page.